{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:52:47Z","timestamp":1792623167908,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.berh.2009.08.003","type":"journal-article","created":{"date-parts":[[2009,10,24]],"date-time":"2009-10-24T08:55:42Z","timestamp":1256374542000},"page":"655-664","source":"Crossref","is-referenced-by-count":112,"title":["Systemic JIA: new developments in the understanding of the pathophysiology and therapy"],"prefix":"10.1016","volume":"23","author":[{"given":"Sebastiaan J.","family":"Vastert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wietse","family":"Kuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei A.","family":"Grom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2009.08.003_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/095952879708000106","article-title":"On a form of chronic joint disease in children","volume":"80","author":"Still","year":"1897","journal-title":"Med-Chir Trans"},{"key":"10.1016\/j.berh.2009.08.003_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0950-3579(98)80018-6","article-title":"Systemic onset juvenile rheumatoid arthritis","volume":"12","author":"Schneider","year":"1998","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.berh.2009.08.003_bib3","first-page":"168","article-title":"Radiologic features of systemic onset juvenile rheumatoid arthritis","volume":"22","author":"Lang","year":"1995","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2009.08.003_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(85)80072-X","article-title":"Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection","volume":"106","author":"Hadchouel","year":"1985","journal-title":"J Pediatr"},{"key":"10.1016\/j.berh.2009.08.003_bib5","first-page":"2513","article-title":"Macrophage activation syndrome\u2013what's in a name!","volume":"30","author":"Ramanan","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.08.003_bib6","first-page":"121","article-title":"Is macrophage activation syndrome a new entity?","volume":"20","author":"Athreya","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2009.08.003_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/art.20198","article-title":"NK dysfunction: a common pathway in systemic onset juvenile rheumatoid arthritis, macrophage activation syndrome and hemophagocytic lymphohistiocytosis","volume":"50","author":"Grom","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0889-8561(01)00009-1","article-title":"Hemophagocytic lymphohistiocytosis","volume":"22","author":"Filipovich","year":"2002","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.berh.2009.08.003_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemopagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.berh.2009.08.003_bib10","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.berh.2009.08.003_bib11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/rheumatology\/keh710","article-title":"Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?","volume":"44","author":"Ramanan","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2009.08.003_bib12","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/art.22981","article-title":"Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome","volume":"56","author":"Fall","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib13","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/art.22644","article-title":"Specific gene expression profiles in systemic juvenile idiopathic arthritis","volume":"56","author":"Ogilvie","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/rheumatology\/kem271","article-title":"New insights in systemic juvenile idiopathic arthritis\u2013from pathophysiology to treatment","volume":"47","author":"Frosch","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2009.08.003_bib15","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/art.24601","article-title":"Gene expression signatures in new onset untreated juvenile idiopathic arthritis","volume":"60","author":"Barnes","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib16","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1084\/jem.20070070","article-title":"Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade","volume":"204","author":"Allantaz","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.berh.2009.08.003_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature02761","article-title":"Inferences, questions and possibilities in Toll-like receptor signaling","volume":"430","author":"Beutler","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.berh.2009.08.003_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002281-200301000-00011","article-title":"The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations","volume":"15","author":"Hull","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.berh.2009.08.003_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ncprheum0681","article-title":"Primer: inflammasomes and interleukin 1\u03b2 in inflammatory disorders","volume":"4","author":"Church","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"Suppl.","key":"10.1016\/j.berh.2009.08.003_bib20","first-page":"70","article-title":"Juvenile rheumatoid arthritis and HLA: report of the Park City III workshop","volume":"33","author":"Nepom","year":"1992","journal-title":"J. Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2009.08.003_bib21","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1002\/art.20425","article-title":"A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage","volume":"50","author":"Thompson","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib22","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/1529-0131(199912)42:12<2577::AID-ANR10>3.0.CO;2-O","article-title":"Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5\u2032-flanking region of the TNFalpha gene and HLA genes","volume":"42","author":"Date","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.berh.2009.08.003_bib24","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/art.11300","article-title":"The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families","volume":"48","author":"Ogilvie","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib25","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#","article-title":"A novel 5\u2032-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis","volume":"44","author":"Donn","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib26","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/art.10882","article-title":"Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis","volume":"48","author":"De Benedetti","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib27","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/art.24137","article-title":"S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin","volume":"58","author":"Wittkowski","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/art.24349","article-title":"The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"Frosch","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","article-title":"Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock","volume":"13","author":"Vogl","year":"2007","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.berh.2009.08.003_bib30","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/art.20268","article-title":"Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome","volume":"50","author":"Maeno","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib31","first-page":"203","article-title":"Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease?","volume":"25","author":"De Benedetti","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.08.003_bib32","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.1780340912","article-title":"Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis","volume":"34","author":"De Benedetti","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib33","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1210\/en.142.11.4818","article-title":"Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis","volume":"142","author":"De Benedetti","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.berh.2009.08.003_bib34","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1182\/blood.V87.11.4824.bloodjournal87114824","article-title":"Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis","volume":"87","author":"Cazzola","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.berh.2009.08.003_bib35","first-page":"2071","article-title":"Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis","volume":"31","author":"Verbsky","year":"2004","journal-title":"J Rheumatol"},{"issue":"Suppl.","key":"10.1016\/j.berh.2009.08.003_bib36","first-page":"S437","article-title":"Treatment of systemic onset juvenile rheumatoid arthritis with anakinra","volume":"50","author":"Irigoyen","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"Suppl.","key":"10.1016\/j.berh.2009.08.003_bib37","first-page":"S438","article-title":"Efficacy of anakinra in refractory systemic arthritis","volume":"50","author":"Henrickson","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"8570","key":"10.1016\/j.berh.2009.08.003_bib38","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(87)91854-X","article-title":"Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis","volume":"2","author":"Prieur","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2009.08.003_bib39","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","article-title":"The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib40","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.08.003_bib41","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jpeds.2005.12.070","article-title":"Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood","volume":"148","author":"Avcin","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.berh.2009.08.003_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0609.2004.00318.x","article-title":"Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome","volume":"74","author":"Schaer","year":"2005","journal-title":"Eur J Haemotol"},{"key":"10.1016\/j.berh.2009.08.003_bib44","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/35051594","article-title":"Identification of the hemoglobin scavenger receptor","volume":"409","author":"Kristiansen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.berh.2009.08.003_bib45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2249.2005.02934.x","article-title":"Macrophage activation switching: an asset for the resolution of inflammation","volume":"142","author":"Porscheray","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.berh.2009.08.003_bib46","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.berh.2009.08.003_bib47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s10165-009-0152-6","article-title":"The role of heme oxygenase-1 in systemic onset juvenile idiopathic arthritis","volume":"19","author":"Takahashi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.berh.2009.08.003_bib48","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.berh.2009.08.003_bib49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.berh.2009.08.003_bib50","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/hmg\/ddi076","article-title":"Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11","volume":"14","author":"zur Stadt","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.berh.2009.08.003_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/76024","article-title":"Mutations in Rab27a cause Griscelli syndrome associated with haemophagocytic syndrome","volume":"25","author":"Menasche","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.berh.2009.08.003_bib52","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/382262a0","article-title":"Identification of the homologous beige and Chediak-Higashi syndrome genes (LYST)","volume":"382","author":"Barbosa","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.berh.2009.08.003_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.berh.2009.08.003_bib54","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nri1983","article-title":"Perforin-mediated target-cell death and immune homeostasis","volume":"6","author":"Voskoboinik","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.berh.2009.08.003_bib55","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0167-5699(00)01622-4","article-title":"Perforin: more than just an effector molecule","volume":"21","author":"Stepp","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.berh.2009.08.003_bib56","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/rheumatology\/keg074","article-title":"Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation","volume":"42","author":"Wulffraat","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2009.08.003_bib57","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1067\/mpd.2003.110","article-title":"Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome","volume":"142","author":"Grom","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.berh.2009.08.003_bib58","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.23734","article-title":"Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms","volume":"58","author":"Zhang","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib59","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study","volume":"66","author":"de Jager","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2009.08.003_bib60","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1128\/JVI.02350-08","article-title":"Potential role of interleukin-18 in the immunopathogenesis of AIDS: involvement in fratricidal killing of NK cells","volume":"83","author":"Iannello","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.berh.2009.08.003_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ncprheum0084","article-title":"Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome","volume":"2","author":"Woo","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.berh.2009.08.003_bib62","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jpeds.2004.08.020","article-title":"Thalidomide for severe systemic onset juvenile rheumatoid arthritis: a multicenter study","volume":"145","author":"Lehman","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.berh.2009.08.003_bib63","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/art.1780401019","article-title":"Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis","volume":"40","author":"Wallace","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib64","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/08916930802200224","article-title":"Current perspectives of autologous stem cell transplantation for severe juvenile idiopathic arthritis","volume":"41","author":"Wulffraat","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.berh.2009.08.003_bib65","first-page":"297","article-title":"Evaluation of methotrexate in the treatment of juvenile chronic arthritis according to the subtype","volume":"9","author":"Halle","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2009.08.003_bib66","first-page":"647","article-title":"Low-dose methotrexate in systemic onset juvenile chronic arthritis","volume":"7","author":"Speckmaier","year":"1989","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2009.08.003_bib67","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","article-title":"Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis","volume":"43","author":"Woo","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib68","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","article-title":"Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis","volume":"58","author":"Lovell","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib69","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib70","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","article-title":"The German etanercept registry for treatment of juvenile idiopathic arthritis","volume":"63","author":"Horneff","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.08.003_bib71","first-page":"935","article-title":"Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis","volume":"32","author":"Kimura","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.08.003_bib72","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3899\/jrheum.090952","article-title":"Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents","volume":"36","author":"Russo","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.berh.2009.08.003_bib73","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","article-title":"Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France","volume":"67","author":"Lequerre","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.08.003_bib74","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/ard.2007.082859","article-title":"Anakinra treatment for systemic juvenile idiopathic arthritis and adult onset Still disease","volume":"67","author":"Woo","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2009.08.003_bib75","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.coph.2004.03.010","article-title":"Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation","volume":"4","author":"Dinarello","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.berh.2009.08.003_bib76","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.23620","article-title":"A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome","volume":"58","author":"Goldbach-Mansky","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2009.08.003_bib77","doi-asserted-by":"crossref","first-page":"R1281","DOI":"10.1186\/ar1826","volume":"7","author":"Woo","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2009.08.003_bib78","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694209000886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694209000886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T08:31:53Z","timestamp":1685176313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694209000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1521694209000886"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2009.08.003","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}